Agenus Inc. (AGEN) financial statements (2022 and earlier)

Company profile

Business Address 3 FORBES ROAD
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:30710062536076172
Cash and cash equivalents29210062536071137
Short-term investments15    535
Other undisclosed cash, cash equivalents, and short-term investments(0)  00(0)0
Receivables2116111110
Inventory, net of allowances, customer advances and progress billings   0000
Inventory   0000
Prepaid expense20117191132
Other current assets3211111
Other undisclosed current assets0  (0)(0)0(0)
Total current assets:33211487757491184
Noncurrent Assets
Operating lease, right-of-use asset31337
Property, plant and equipment60272625262615
Intangible assets, net (including goodwill)33363435373942
Goodwill25252323232223
Intangible assets, net (excluding goodwill)8111112141619
Other noncurrent assets10411111
Total noncurrent assets:1341016962656658
TOTAL ASSETS:466215155136138157242
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities73464538303319
Accounts payable30171414854
Accrued liabilities42293125222814
Deferred revenue121729
Debt1220 00
Deferred revenue and credits434
Contract with customer, liability2
Other liabilities7600256
Other undisclosed current liabilities6459462721  
Total current liabilities:15713012268564129
Noncurrent Liabilities
Long-term debt and lease obligation, including:55532113142131114
Long-term debt, excluding current maturities13191313142131114
Finance lease, liability00 
Operating lease, liability42348
Other undisclosed long-term debt and lease obligation    (0)(0) 
Liabilities, other than long-term debt1440417152528
Deferred revenue and credits81215
Deferred revenue112828
Contract with customer, liability1
Other liabilities2243358
Business combination, contingent consideration, liability21093486
Other undisclosed noncurrent liabilities191203202223   
Total noncurrent liabilities:261296264243158155143
Total liabilities:418426387311214196172
Stockholders' equity
Stockholders' equity attributable to parent, including:34(204)(225)(172)(76)(39)71
Common stock3211111
Additional paid in capital1,5201,2581,0601,005952867851
Accumulated other comprehensive income (loss)13(1)(2)(2)(2)(2)
Accumulated deficit(1,490)(1,466)(1,285)(1,177)(1,026)(905)(779)
Other undisclosed stockholders' equity attributable to parent   0000
Stockholders' equity attributable to noncontrolling interest13(8)(6)(2)   
Total stockholders' equity:48(211)(231)(175)(76)(39)71
Other undisclosed liabilities and equity    00 
TOTAL LIABILITIES AND EQUITY:466215155136138157242

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2968815037432325
Cost of revenue(3)(2)     
Gross profit:2928615037432325
Operating expenses(255)(202)(214)(162)(150)(128)(99)
Other undisclosed operating income (loss)(11)(1)(6)13(2)(7)
Operating income (loss):26(117)(70)(124)(104)(107)(81)
Nonoperating income (expense)5(2)0(2)2(2)(6)
Investment income, nonoperating   1112
Foreign currency transaction gain (loss), before tax1(3)0(2)2(2)(1)
Interest and debt expense6  (11)(31)(19)(0)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes    122(6)
Income (loss) from continuing operations before income taxes:37(119)(70)(137)(121)(127)(93)
Income tax benefit      5
Income (loss) before gain (loss) on sale of properties:37(119)(70)(137)(121)(127)(88)
Other undisclosed net loss(66)(64)(41)(25)   
Net loss:(29)(183)(112)(162)(121)(127)(88)
Net income attributable to noncontrolling interest5242   
Net loss attributable to parent:(24)(181)(108)(160)(121)(127)(88)
Preferred stock dividends and other adjustments(0)(0)(0)(0)(0)(0) 
Other undisclosed net loss available to common stockholders, basic      (0)
Net loss available to common stockholders, diluted:(24)(181)(108)(160)(121)(127)(88)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(29)(183)(112)(162)(121)(127)(88)
Other comprehensive income (loss)(1)401(1)1(0)
Comprehensive loss:(30)(179)(111)(161)(121)(126)(88)
Comprehensive income, net of tax, attributable to noncontrolling interest5242   
Other undisclosed comprehensive loss, net of tax, attributable to parent      (0)
Comprehensive loss, net of tax, attributable to parent:(25)(177)(107)(159)(121)(126)(88)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: